81 related articles for article (PubMed ID: 8398902)
1. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells.
Liu J; Shoyab M; Grove RI
Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902
[TBL] [Abstract][Full Text] [Related]
2. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
Liu J; Grove RI; Vestal RE
Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
5. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J
Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways mediating induction of the early response genes prostaglandin G/H synthase-2 and egr-1 by serotonin via 5-HT2A receptors.
Goppelt-Struebe M; Stroebel M
J Cell Physiol; 1998 Jun; 175(3):341-7. PubMed ID: 9572479
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor up-regulates expression of low-density lipoprotein receptors on HepG2 cells.
Liao W; Florén CH
Hepatology; 1993 May; 17(5):898-907. PubMed ID: 8387950
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
12. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M.
Liu J; Clegg CH; Shoyab M
Cell Growth Differ; 1992 May; 3(5):307-13. PubMed ID: 1633113
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.
Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X
Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136
[TBL] [Abstract][Full Text] [Related]
14. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
16. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.
Sakaue M; Adachi H; Dawson M; Jetten AM
Cell Death Differ; 2001 Apr; 8(4):411-24. PubMed ID: 11550093
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the Egr-1 gene mediated by tetradecanoylphorbol acetate and extracellular signal-regulated protein kinase.
Bauer I; Hohl M; Al-Sarraj A; Vinson C; Thiel G
Arch Biochem Biophys; 2005 Jun; 438(1):36-52. PubMed ID: 15910736
[TBL] [Abstract][Full Text] [Related]
19. Early Growth Response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia.
Nishi H; Nishi KH; Johnson AC
Cancer Res; 2002 Feb; 62(3):827-34. PubMed ID: 11830539
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M suppresses EGF-mediated protein tyrosine phosphorylation in breast cancer cells.
Spence MJ; Vestal RE; Ma Y; Streiff R; Liu J
Cytokine; 2000 Jul; 12(7):922-33. PubMed ID: 10880237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
